Japan Chemical Daily

Japan's leading chemical industry newspaper

Log In

Nanocarrier Plans US Clinical Trials for Antibody-Drug Conjugated Micelles

Filed Under: Innovation, Pharma Tagged With: , , , ,

Nanocarrier Co. Ltd. (TYO:4571) plans to apply in fiscal 2018 to conduct Phase I clinical trials in the U.S. using…...

Please subscribe to read the full story.

Subscribe Free Trial

Related Articles:

NOF Moves to Boost Production of DDS Materials for Biopharmaceuticals
NOF Moves to Boost Production of DDS Materials for…
Coronavirus Report – Part 58: Clinical Trials Begin for Slew of Potential Vaccines
Coronavirus Report – Part 58: Clinical Trials Begin for Slew…
Coronavirus Report – Part 67: Pandemic Causes 75% Drop in Clinical Trials for Early April
Coronavirus Report – Part 67: Pandemic Causes 75% Drop in…
Coronavirus Report – Part 77: Japan’s Pharmaceutical Companies Move in Quick Order to Treat Infection
Coronavirus Report – Part 77: Japan’s Pharmaceutical…
Coronavirus Report – Part 27: Pandemic Sees Clinical Trials for New Drugs Suspended, Postponed
Coronavirus Report – Part 27: Pandemic Sees Clinical Trials…
Coronavirus Report — Part 72: Japanese Research Group Discovers Infection-Suppressing VHH Antibody
Coronavirus Report — Part 72: Japanese Research Group…